NYSE:RCUS

Arcus Biosciences Stock Forecast

etoro logo Buy RCUS
*Your capital is at risk
$19.99
-0.0800 (-0.399%)
At Close: Nov 17, 2025
AI Analysis AI Analysis of RCUS
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Red day on Monday for Arcus Biosciences Inc. stock after losing 0.399%
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jul 16, 2025 Gain 115.87%

The Arcus Biosciences Inc. stock price fell by -0.399% on the last day (Monday, 17th Nov 2025) from $20.07 to $19.99. During the last trading day the stock fluctuated 6.16% from a day low at $19.64 to a day high of $20.85. The price has fallen in 7 of the last 10 days and is down by -1.77% for this period. Volume has increased on the last day by 628 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $29.55 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 112.41% during the next 3 months and, with a 90% probability hold a price between $40.44 and $47.12 at the end of this 3-month period.

RCUS Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Monday, November 03, 2025, and so far it has fallen -1.77%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. The Arcus Biosciences Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $19.84 and $17.51. A breakdown below any of these levels will issue sell signals.

Support, Risk & Stop-loss for Arcus Biosciences Inc. stock

Arcus Biosciences Inc. finds support from accumulated volume at $19.88 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.21 between high and low, or 6.16%. For the last week, the stock has had daily average volatility of 5.64%.

Our recommended stop-loss: $19.32 (-3.33%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 10 days ago.)

Trading Expectations (RCUS) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Arcus Biosciences Inc. to open at $20.16, and during the day (based on 14 day Average True Range), to move between $19.43 and $20.55, which gives a possible trading interval of +/-$1.13 (+/-5.79%) up or down from last closing price. If Arcus Biosciences Inc. takes out the full calculated possible swing range there will be an estimated 5.79% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $20.00 (0.05%) than the support at $19.88 (0.55%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Arcus Biosciences Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Arcus Biosciences Inc. stock to perform well in the short-term.

Current score: 3.168 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $20.16 ( 0.85%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

RCUS Performance

Trading levels for RCUS

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 21.37 6.90%
R2 20.91 4.59%
R1 20.62 3.16%
Price 19.99
S1 19.70 -1.46%
S2 19.41 -2.89%
S3 18.95 -5.20%

Accumulated Volume Support & Resistance Levels

Level Price
R3 20.35 1.80%
R2 20.29 1.50%
R1 20.00 0.0500%
Price 19.99
S1 19.88 -0.550%
S2 19.72 -1.35%
S3 18.60 -6.95%

FAQ

What is the symbol for Arcus Biosciences Inc. Stock and on which exchange is it traded?
The symbol for Arcus Biosciences Inc. is RCUS and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Arcus Biosciences Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Arcus Biosciences Inc. stock to perform well in the short-term.

How to buy Arcus Biosciences Inc. Stock?
Arcus Biosciences Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Arcus Biosciences Inc. Stock.

What's the current price of Arcus Biosciences Inc. Stock?
As of the end of day on the Nov 17, 2025, the price of an Arcus Biosciences Inc. (RCUS) share was $19.99.

What is the 52-week high and low for Arcus Biosciences Inc. Stock?
The 52-week high for Arcus Biosciences Inc. Stock is $22.11 and the 52-week low is $6.50.

What is the market capitalization of Arcus Biosciences Inc. Stock?
As of the Nov 17, 2025, the market capitalization of Arcus Biosciences Inc. is 2.158B.

When is the next earnings date for Arcus Biosciences Inc.?
The upcoming earnings date for Arcus Biosciences Inc. is Feb 24, 2026.
Click to get the best stock tips daily for free!
ABOUT ARCUS BIOSCIENCES INC.
Arcus Biosciences
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for monotherapy. The company also develops Domvanalimab, an anti-TIGIT monoclonal antibody, which is in Pha...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE